Paulien G de Jong
Overview
Explore the profile of Paulien G de Jong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quenby S, Booth K, Hiller L, Coomarasamy A, de Jong P, Hamulyak E, et al.
Lancet
. 2023 Jun;
402(10395):54-61.
PMID: 37271152
Background: Anticoagulant therapy might reduce the number of miscarriages and adverse pregnancy outcomes in women with recurrent pregnancy loss and inherited thrombophilia. We aimed to assess use of low-molecular-weight heparin...
2.
Hamulyak E, de Jong P, Scheres L, Ewington L, Middeldorp S, Quenby S, et al.
Thromb Res
. 2020 Apr;
190:39-44.
PMID: 32298839
Investigator-initiated studies are invaluable, especially in fields that are not particularly of interest for the pharmaceutical industry because they are either less profitable or concern special patient groups such as...
3.
van Mens T, Scheres L, de Jong P, Leeflang M, Nijkeuter M, Middeldorp S
Cochrane Database Syst Rev
. 2017 Jan;
1:CD011053.
PMID: 28124411
Background: Pulmonary embolism is a leading cause of pregnancy-related death. An accurate diagnosis in pregnant patients is crucial to prevent untreated pulmonary embolism as well as unnecessary anticoagulant treatment and...
4.
de Jong P, Quenby S, Bloemenkamp K, Braams-Lisman B, de Bruin J, Coomarasamy A, et al.
Trials
. 2015 May;
16:208.
PMID: 25947329
Background: A large number of studies have shown an association between inherited thrombophilia and recurrent miscarriage. It has been hypothesized that anticoagulant therapy might reduce the number of miscarriages and...
5.
de Jong P, Hiddink L, Meijers J, Kiemeney L, Heerde W, Middeldorp S
Br J Haematol
. 2014 Nov;
169(2):301-4.
PMID: 25382354
No abstract available.
6.
de Jong P, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S
Cochrane Database Syst Rev
. 2014 Jul;
(7):CD004734.
PMID: 24995856
Background: Since hypercoagulability might result in recurrent miscarriage, anticoagulant agents could potentially increase the chance of live birth in subsequent pregnancies in women with unexplained recurrent miscarriage, with or without...
7.
de Jong P, Goddijn M, Middeldorp S
Hum Reprod Update
. 2013 Jun;
19(6):656-73.
PMID: 23766357
BACKGROUND Although an association between thrombophilia and pregnancy loss has been observed in many studies, little is known about the pathophysiological mechanisms behind this association. Considering the association between thrombophilia...
8.
de Jong P, Coppens M, Middeldorp S
Br J Haematol
. 2012 Jun;
158(4):433-41.
PMID: 22734929
Venous thromboembolism (VTE) is effectively treated with anticoagulant therapy. After an initial treatment phase, extended treatment is effective to prevent recurrence after a first event but this is at the...
9.
de Jong P, Goddijn M, Middeldorp S
Semin Reprod Med
. 2011 Dec;
29(6):540-7.
PMID: 22161466
Approximately 1-5% of women trying to conceive experience recurrent miscarriage, and in 50% of these women, the cause of the preceding miscarriages is unknown. Inherited thrombophilias such as factor V...